Search

Medpace Holdings Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

615.65 3.57

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

590

Max

603.52

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-2.5M

121M

Pardavimai

727K

707M

P/E

Sektoriaus vid.

36.436

47.946

Pelnas, tenkantis vienai akcijai

4.25

Pelno marža

17.158

Darbuotojai

6,500

EBITDA

-21M

134M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+1.3% upside

Dividendai

By Acuity

Kitas uždarbis

2026-10-21

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

2.2B

17B

Ankstesnė atidarymo kaina

612.08

Ankstesnė uždarymo kaina

615.65

Medpace Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-10-08 21:40; UTC

Medpace Holdings Inc is trading lower in after-market hours, continuing a decline since Thursday's close and indicating ongoing weakness below its 20-day moving average.

2026-10-06 20:00; UTC

Correlated Moves
News

Medpace Holdings Inc shares fell amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving the company and its officers.

2026-10-05 20:01; UTC

Correlated Moves

Charles River Laboratories is sharply higher after a positive earnings report, while Medpace Holdings is also advancing, despite earlier pulling back from a session high.

2026-10-01 20:02; UTC

Correlated Moves

Medpace Holdings Inc shares fell amid a broader market decline, reversing the recent trend of higher daily closes since Wednesday's close.

2026-09-30 19:35; UTC

News

UBS upgraded Medpace Holdings Inc to Neutral with a price target of $673, as shares trade higher amid strong historical performance despite recent insider selling.

2026-09-25 20:07; UTC

Correlated Moves

Medpace Holdings Inc shares fell, reflecting a decline from Thursday's close, amid sympathy with Thermo Fisher Scientific Inc, which is also down.

2026-09-24 20:07; UTC

Correlated Moves
News

Medpace shares are modestly higher as President and CEO August J. Troendle sold 70.9k shares for about $44.43 million, following strong revenue growth.

2026-09-23 20:01; UTC

Correlated Moves

Medpace Holdings Inc shares fell sharply on Wednesday, aligning with a decline in Charles River Laboratories, despite remaining above its 20-day moving average.

2026-09-22 23:01; UTC

Medpace Holdings Inc is rising in after-market trading, continuing a trend above its 20-day moving average and closing higher for three consecutive sessions.

2026-09-15 20:01; UTC

Medpace Holdings Inc. is trading higher today despite negative broader market sentiment following a significant drop in the NY Empire State Manufacturing Index.

2026-09-11 20:08; UTC

Medpace Holdings Inc. is advancing during Friday's session, having reached a session high earlier, though it has since pulled back from that peak.

2026-09-03 20:07; UTC

News

Medpace Holdings shares are declining amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing involving the company and its officers.

2026-09-02 20:08; UTC

Medpace Holdings Inc. is rising amid broader gains in the Life Sciences Tools & Services sector, despite no specific company news driving the movement.

2026-09-01 20:08; UTC

Correlated Moves
News

Medpace Holdings Inc shares are lower amid insider selling and an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing.

2026-08-31 20:07; UTC

Correlated Moves

Medpace Holdings shares are lower today, reflecting broader sector dynamics and rising interest rate expectations following the Jackson Hole Economic Symposium.

2026-08-26 20:08; UTC

Medpace Holdings Inc. shares are higher today, continuing an upward trend since Tuesday's close. The stock remains above its 20-day moving average.

2026-08-25 20:07; UTC

News

Shares of Medpace Holdings Inc are trading lower amid an investigation by Bronstein, Gewirtz & Grossman, LLC into potential corporate wrongdoing by company officers.

2026-08-20 19:41; UTC

Social Media

Medpace Holdings Inc. is rising amid strong gains in the Life Sciences Tools & Services sector and positive sentiment surrounding biotech investments.

2026-08-19 20:02; UTC

Medpace Holdings Inc. shares are higher, driven by a significant advance in the Life Sciences Tools & Services sub-sector amid a strong market session.

2026-08-17 20:02; UTC

News

Medpace Holdings Inc. shares are higher following a Barron's report suggesting significant upside potential and robust Q2 results exceeding analyst expectations.

2026-08-14 19:36; UTC

Medpace Holdings Inc shares are lower amid broader market sentiment following a Commerce Department report showing a decline in retail sales for July.

2026-08-13 19:56; UTC

News

Medpace Holdings shares are lower as CEO August J. Troendle sold 23,144 shares valued at $13.98 million, raising investor concerns about future performance.

2026-08-07 19:16; UTC

Medpace Holdings Inc. shares are lower today, reflecting a slight pullback amid broader market factors, including economic signals and geopolitical tensions.

2026-08-03 19:26; UTC

Medpace Holdings Inc shares are higher, tracking broader market gains as major technology stocks boost investor confidence amid declining energy prices.

2026-07-30 19:22; UTC

Medpace Holdings Inc is trading lower amid significant declines in the Life Sciences Tools & Services sub-sector, with unusual volatility noted during Thursday's session.

2026-07-29 18:44; UTC

Macro Event

Medpace Holdings Inc. is trading higher, buoyed by the Federal Reserve's steady interest rates, despite broader market pressures from rising oil prices and geopolitical tensions.

2026-07-28 23:11; UTC

Medpace Holdings Inc shares are higher in after-market hours, rebounding after four consecutive lower closes and remaining above the 20-day moving average.

2026-07-27 16:56; UTC

News

Medpace Holdings Inc. shares are lower amid broader market volatility, despite reporting strong Q2 2026 business awards and raising guidance.

2026-07-24 18:26; UTC

News

Analyst upgrades from RBC Capital and Truist Securities boost Medpace Holdings' price targets, contributing to modest gains during Friday's trading session.

2026-07-22 23:22; UTC

Social Media
News

Medpace Holdings Inc. reported Q2 revenue of $707.3 million, exceeding expectations, and raised 2026 guidance, driving shares higher in after-market trading.

Akcijų palyginimas

Kainos pokytis

Medpace Holdings Inc Prognozė

Kainos tikslas

By TipRanks

1.3% į viršų

12 mėnesių prognozė

Vidutinis 612.1 USD  1.3%

Aukščiausias 700 USD

Žemiausias 492 USD

Remiantis 12 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Medpace Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

12 ratings

2

Pirkti

10

Laikyti

0

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Medpace Holdings Inc

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. It provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, the company offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.